Recent advances in the treatment of acute myocardial infarction.
A number of recent major clinical trials have added substantially to the understanding of what the current "optimal" therapy for acute myocardial infarction may include. This review highlights a number of studies that have been published or presented within the last 2 years. Clearly, there is still room for improvement, but we have made considerable progress in recent years, and the pace of our advances continues to accelerate.
Ferguson
J J
JJ
Texas Heart Institute, St. Luke's Episcopal Hospital, Baylor College of Medicine, Houston, USA.
D015906:Angioplasty, Balloon, Coronary; D003131:Combined Modality Therapy; D005500:Follow-Up Studies; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D015337:Multicenter Studies as Topic; D009203:Myocardial Infarction / Q000401:mortality / Q000628:therapy*; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage*; D016032:Randomized Controlled Trials as Topic; D015996:Survival Rate; D015912:Thrombolytic Therapy
D010975:Platelet Aggregation Inhibitors